MedPath

Effect of radiation according to therapeutic nuclear medicine on DNA

Not Applicable
Conditions
Thyroid cancer
Registration Number
JPRN-UMIN000034968
Lead Sponsor
agasaki University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are pregnant or possibly pregnant. Patients who are performing breast feeding to baby.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes of DNA damage between bef ore I-131 administration and three days after administration.
Secondary Outcome Measures
NameTimeMethod
correlation between DNA damage and blood sample data/history/therapeutic record/I-131 dose/emitted radiation dose from patient.
© Copyright 2025. All Rights Reserved by MedPath